NCT01212341View on ClinicalTrials.gov

Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

March 31, 2013

Conditions
Malignant LymphomasSolid Tumors
Interventions
BIOLOGICAL

Allogeneic NK cells

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

GC Biopharma Corp
All Listed Sponsors
collaborator

GC Biopharma Corp

INDUSTRY

lead

Seoul National University Hospital

OTHER